Mutation-specific cluster regions (CR) in both genes have been identified for breast (BCCR) and ovarian (OCCR) cancer, aiding in the monitoring of patients with PVs in BRCA1 and BRCA2 [23]. Here, BRCA2 is linked to cancer.